A study was conducted to evaluate and quantify a precision of the interfraction setup with different immobilisation devices throughout the treatment time. Local setup accuracy was analysed for 8 oral cancer patients receiving radiotherapy; 4 with HeadFIX^® mouthpiece moulded with wax (HFW) and 4 with 10 ml/cc syringe barrel (SYR). Each patients underwent Image Guided Radiotherapy (IGRT) with total of 209 cone-beam computed tomography (CBCT) data sets for position set up errors measurement. The setup variations in the mediolateral (ML), craniocaudal (CC), and anteroposterior (AP) dimensions were measured. Overall mean displacement (M), the population systematic (Σ) and random (σ) errors and the 3D vector length were calculated. Clinical target volume to planning target volume (CTV-PTV) margins were calculated according to the van Herk formula (2.5Σ+0.7σ). The M values for both group were < 1 mm and < 1° in all translational and rotational directions. This indicate there is no significant imprecision in the equipment (lasers) and during procedure. The interfraction translational 3 dimension vector for HFW and SYR were 1.93±0.66mm and 3.84±1.34mm, respectively. The interfraction average rotational error were 0.00°±0.65° and 0.34°±0.59°, respectively. CTV-PTV margins along the 3 translational axis (Right-Left, Superior-Inferior, Anterior-Posterior) calculated were 3.08, 2.22 and 0.81 mm for HFW and 3.76, 6.24 and 5.06 mm for SYR. The results of this study have demonstrated that HFW more precise in reproducing patient position compared to conventionally used SYR (p<0.001). All margin calculated did not exceed hospital protocol (5mm) except S-I and A-P axes using syringe. For this reason, a daily IGRT is highly recommended to improve the immobilisation precision.

1. Ben-David, M. A., Diamante, M., Radawski, J. D., Vineberg, K. A., Stroup, C., Murdoch-Kinch, C., Zwetchkenbaum, S. R., & Eisbruch, A. (2007). Lack of osteoradionecrosis of the mandible after IMRT for head and neck cancer: Likely contributions of both dental care and improved dose distributions. International Journal of Radiation Oncology, Biology, Physics, 68(2), 396–402.
2. Bodard, A. G., Racadot, S., Salino, S., Pommier, P., Zrounba, P., & Montbarbon, X. (2009). A new, simple maxillary-sparing tongue depressor for external mandibular radiotherapy: A case report. Head & Neck, 31, 1528–1530.
3. Ch’ng, S., Oates, J., Gao, K., Foo, K., Davies, S., Brunner, M., & Clark, J. R. (2014). Prospective quality of life assessment between treatment groups for oral cavity squamous cell carcinoma. Head & Neck, 36, e834–e840.
4. Hong, T. S., Tomé, W. A., Chappell, R. J., Chinnaiyan, P., Mehta, M. P., & Harari, P. M. (2005). The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 61(3), 779–788.
5. Johnson, B., Sales, L., Winston, A., Liao, J., Laramore, G., & Parvathaneni, U. (2013). Fabrication of customized tongue-displacing stents. Journal of the American Dental Association, 144(6), 594–600.
6. Kaanders, J. H. A. M., Fleming, T. J., Ang, K. K., Maor, M. H., & Peters, L. J. (1992). Devices valuable in head and neck radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 23(3), 639–645.
7. Lee, T. F., Ting, H. M., Chao, P. J., & Fang, F. M. (2012). Dual arc volumetric-modulated arc radiotherapy (VMAT) of nasopharyngeal carcinomas: A simultaneous integrated boost treatment plan comparison with intensity-modulated radiotherapies and single arc VMAT. Clinical Oncology, 24(3), 196–207.
8. Nagler, R. M., & Baum, B. J. (2003). Prophylactic treatment reduces the severity of xerostomia following radiation therapy for oral cavity cancer. Archives of Otolaryngology–Head & Neck Surgery, 129(2), 247–250.
9. Niewald, M., Mang, K., Barbie, O., Fleckenstein, J., Holtmann, H., Spitzer, W. J., & Rübe, C. (2014). Dental status, dental treatment procedures and radiotherapy as risk factors for infected osteoradionecrosis (IORN) in patients with oral cancer: A comparison of two 10 years’ observation periods. SpringerPlus, 3, Article 263.
10. Sales, L. R., Liao, J., Johnson, B., Winston, A., Laramore, G., & Parvathaneni, U. (2011). Customized tongue-displacing dental stents for oral mucosal sparing and immobilisation in head and neck radiotherapy. In Proceedings of the American Society for Radiation Oncology 53rd Annual Meeting (p. S493).
11. Simon, V. K., Suzanne, V. B., Coen, R., Marcel, V. K., & Jan, J. S. (2009). Setup uncertainties of anatomical sub-regions in head-and-neck cancer patients after offline CBCT guidance. International Journal of Radiation Oncology, Biology, Physics, 73(5), 1566–1573.
12. Teoh, M., Clark, C. H., Wood, K., Whitaker, S., & Nisbet, A. (2011). Volumetric modulated arc therapy: A review of current literature and clinical use in practice. British Journal of Radiology, 84(1007), 967–996.
13. Van Herk, M., Remeijer, P., Rasch, C., & Lebesque, J. V. (2000). The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 47(4), 1121–1135.
14. Van Herk, M. (2004). Errors and margins in radiotherapy. Seminars in Radiation Oncology, 14(1), 52–64.
15. Verrone, J. R., Alves, F. D. A., Prado, J. D., Boccaletti, K. W., Sereno, M. P., Silva, M. L. G., & Jaguar, G. C. (2013). Impact of intraoral stent on the side effects of radiotherapy for oral cancer. Head & Neck, 35, e213–e217.